Drug
Pro 240
Pro 240: highest development phase Phase 1, developed by Laboratorios Sophia S.A de C.V.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Laboratorios Sophia S.A de C.V.
Trials
| Drug | Phase | Indication |
|---|---|---|
| PRO-240 NCT06375343 | Phase 1 | Dry Eye Disease |
Latest
No recent events.
Follow Pro 240 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.